Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.

MLA

Sabbatini, P. J., et al. “Immunization of Ovarian Cancer Patients with a Synthetic Lewis(y)-Protein Conjugate Vaccine: A Phase 1 Trial.” International Journal of Cancer, vol. 87, no. 1, July 2000, pp. 79–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10861456&authtype=sso&custid=ns315887.

APA

Sabbatini, P. J., Kudryashov, V., Ragupathi, G., Danishefsky, S. J., Livingston, P. O., Bornmann, W., Spassova, M., Zatorski, A., Spriggs, D., Aghajanian, C., Soignet, S., Peyton, M., O’Flaherty, C., Curtin, J., & Lloyd, K. O. (2000). Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial. International Journal of Cancer, 87(1), 79–85.

Chicago

Sabbatini, P J, V Kudryashov, G Ragupathi, S J Danishefsky, P O Livingston, W Bornmann, M Spassova, et al. 2000. “Immunization of Ovarian Cancer Patients with a Synthetic Lewis(y)-Protein Conjugate Vaccine: A Phase 1 Trial.” International Journal of Cancer 87 (1): 79–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10861456&authtype=sso&custid=ns315887.